EUA Template for At-Home COVID-19 Sample Collection Kits

by | Jun 12, 2020 | Coronavirus, COVID-19, FDA, Medical Devices, Requirements

The FDA has recently released a new emergency use authorization (EUA) template aimed at developers of at-home sample collection kits for COVID-19 tests. EUA’s are the FDA’s provision which allows the use of unapproved medical products when there are no other adequate or available alternatives. This newly released template lays out the FDA’s current thinking on what data and information developers should submit in order to facilitate and streamline the EUA process.

The template is aimed at home sample collection for molecular diagnostic testing which is developed by either laboratories or commercial manufacturers. Additionally, this template only applies to prescription use home collection devices that utilize anterior nasal swab or saliva specimens. Any developers who are considering other types of specimens (i.e. tongue swabs or stool samples) are instructed to contact the FDA directly to discuss validation strategy.1

The template information itself walks the developer through all the information necessary to submit the EUA. It covers administrative information such as purpose for submission, applicant information, and even has a pre-filled approval/clearance status disclaimer. The template then moves into the proposed intended use section, which is partially completed and has easy-to-understand fillable sections. The information the developer is responsible for completing includes what type of specimen the device collects, the mechanism via which the individual is determined to be appropriate for COVID-19 testing, and the name of the laboratories that will be testing the samples. Other sections of the template walk developers through:

  • Device Description (including specimen collection control and processing)
  • Product Manufacturing
  • Performance Evaluation
  • Instructions for Use
  • Record Keeping and Reporting Information to the FDA2

The FDA has been developing EUA templates as part of an interactive review for Pre-EUA/EUA submissions and will likely continue to update them to facilitate the application process for developers. If you are developing a home sample collection kit for COVID-19 and need help applying for an EUA, EMMA International has the expertise to help! Give us a call at 248-987-4497 or email to get started.

1FDA (May 2020) FDA takes steps to streamline development of tests with at-home sample collection retrieved on 06/10/2020 from:

2FDA (May 2020) Policy for Coronavirus Disease-2019 Tests during the Public Health Emergency (Revised) retrieved on 06/10/2020 from:

Madison Green

Madison Green

Director of Technical Operations - Mrs. Green serves as EMMA International’s Director of Technical Operations. She has experience in technical writing, nonconforming product management, issue evaluations, and implementing corrective and preventative actions in the pharmaceuticals and medical device industries. She has experience cross-functionally between R&D, lean manufacturing operations, and RA compliance. Mrs. Green also has academic and work experience with human health-risk engineering controls, physiological biophysics, and clinical research. Mrs. Green holds a Bachelor of Science in Biosystems Engineering with a concentration in Biomedical Engineering from Michigan State University. She is also a Certified Quality Auditor (CQA), and is currently pursuing her M.S. in Quality Management.

More Resources

Establishing a Culture of Compliance

Establishing a Culture of Compliance

While having robust compliance policies and procedures in place is essential for meeting regulatory requirements, it's equally important to establish a culture of compliance within your organization.  A culture of compliance means that every employee understands the importance of compliance and is committed to upholding it in all their work. Here are some tips for establishing a culture of compliance...
Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...

Ready to learn more about working with us?

Pin It on Pinterest

Share This